Nikkiso Co

Nikkiso Co EBIT/Assets

The Operating Income to Assets Ratio (EBIT/Assets) of Nikkiso Co (6376.T) as of Oct 26, 2026 is 4.16 %. In the previous year, Operating Income to Assets Ratio (EBIT/Assets) was 1.94 % — a change of 114.25% (higher).

EBIT/Assets

4.16 %

YoY

114.25%

Last updated:

Operating Income to Assets Ratio (EBIT/Assets) of Nikkiso Co is 2025 4.16 % . Operating Income to Assets Ratio (EBIT/Assets) of Nikkiso Co was 2024 1.94 % . It decreases by 114.25% higher compared to the previous year.

The Nikkiso Co EBIT/Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT/Assets
Date
EBIT/Assets
Jan 1, 2018
3.94 JPY
Jan 1, 2019
4.29 JPY
Jan 1, 2020
3.25 JPY
Jan 1, 2021
0.84 JPY
Jan 1, 2022
11.84 JPY
Jan 1, 2023
1.54 JPY
Jan 1, 2024
1.94 JPY
Jan 1, 2025
4.16 JPY
The Nikkiso Co EBIT/Assets history
YEAREBIT/AssetsYoY
4.16 %+114.25%
1.94 %+26.14%
1.54 %-86.99%
11.84 %+1,308.08%
0.84 %-74.13%
3.25 %-24.35%
4.29 %+8.88%
3.94 %+31.59%
3.00 %-28.07%
4.17 %+44.44%
2.89 %-14.58%
3.38 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Nikkiso Co Stock analysis

What does Nikkiso Co do? Nikkiso Co., Ltd. generates revenue through the manufacture, sale, and maintenance of industrial and medical equipment across two distinct business segments. The Industrial Business segment focuses on industrial special pumps, liquefied gas and industrial gas related equipment, as well as precision equipment, aerospace, and deep ultraviolet light emitting diode (LED) products. This segment serves customers requiring specialized industrial machinery and advanced technological components. The Medical Business segment drives income by producing and maintaining dialysis-related products such as artificial dialysis machines, dialyzers, blood circuits, and powder-type dialysis agents. Additionally, the company offers products and medicines for CRRT, artificial pancreas devices for blood glucose management, and energy devices for microwave surgery. These offerings cater to healthcare providers and patients requiring acute blood purification and chronic disease management solutions. Nikkiso Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Nikkiso Co stock

Operating Income to Assets Ratio (EBIT/Assets) of Nikkiso Co is 4.16 % in 2025.

Operating Income to Assets Ratio (EBIT/Assets) of Nikkiso Co changed from 1.94 % to 4.16 %, representing a 114.25% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Income to Assets Ratio (EBIT/Assets) Nikkiso Co since 2006 – with annual values, charts, and detailed analysis.

EBIT/Assets measures operating profitability relative to total assets, providing an unlevered view of asset efficiency that is comparable across capital structures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Income to Assets Ratio (EBIT/Assets)'s Nikkiso Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Income to Assets Ratio (EBIT/Assets)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Income to Assets Ratio (EBIT/Assets).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Nikkiso Co

All Key Metrics — Nikkiso Co